| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |